Artemis Medicare Services Limited (NSE:ARTEMISMED)
270.68
-10.44 (-3.71%)
May 12, 2026, 3:30 PM IST
Artemis Medicare Services Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 10,812 | 9,369 | 8,786 | 7,374 | 5,548 |
Other Revenue | 298.29 | - | - | - | - |
| 11,111 | 9,369 | 8,786 | 7,374 | 5,548 | |
Revenue Growth (YoY) | 18.59% | 6.64% | 19.14% | 32.92% | 35.85% |
Cost of Revenue | 8,177 | 7,392 | 7,010 | 5,993 | 4,629 |
Gross Profit | 2,934 | 1,977 | 1,776 | 1,381 | 918.6 |
Selling, General & Admin | - | 106.2 | 82.91 | 100.2 | 48.91 |
Other Operating Expenses | 753.78 | 335.23 | 352.76 | 325.88 | 171.37 |
Operating Expenses | 1,234 | 896.03 | 841.15 | 742.22 | 453.51 |
Operating Income | 1,699 | 1,081 | 934.57 | 639.07 | 465.09 |
Interest Expense | -276.87 | -285.08 | -277.61 | -172.5 | -93.58 |
Interest & Investment Income | - | 266.25 | 42.53 | 29.76 | 14.89 |
Currency Exchange Gain (Loss) | - | 6.93 | 7.38 | 10.16 | 4.91 |
Other Non Operating Income (Expenses) | - | -13.79 | -24.48 | -11.85 | -14.25 |
EBT Excluding Unusual Items | 1,423 | 1,055 | 682.39 | 494.65 | 377.06 |
Gain (Loss) on Sale of Assets | - | -0.57 | 2.14 | 11.41 | -5.21 |
Other Unusual Items | -30.74 | 21.92 | - | - | - |
Pretax Income | 1,392 | 1,077 | 684.53 | 506.06 | 371.85 |
Income Tax Expense | 354.63 | 254.9 | 193.08 | 125.95 | 57.83 |
Earnings From Continuing Operations | 1,037 | 821.76 | 491.45 | 380.11 | 314.02 |
Minority Interest in Earnings | -0.96 | 4.5 | -0.04 | 5.87 | 4.13 |
Net Income | 1,036 | 826.26 | 491.41 | 385.98 | 318.14 |
Net Income to Common | 1,036 | 826.26 | 491.41 | 385.98 | 318.14 |
Net Income Growth | 25.41% | 68.14% | 27.32% | 21.32% | 390.52% |
Shares Outstanding (Basic) | 158 | 154 | 136 | 133 | 132 |
Shares Outstanding (Diluted) | 158 | 156 | 139 | 139 | 139 |
Shares Change (YoY) | 1.45% | 11.81% | 0.48% | -0.31% | 5.02% |
EPS (Basic) | 6.56 | 5.37 | 3.62 | 2.89 | 2.40 |
EPS (Diluted) | 6.56 | 5.31 | 3.53 | 2.79 | 2.29 |
EPS Growth | 23.54% | 50.42% | 26.52% | 21.83% | 367.40% |
Free Cash Flow | 270.01 | 524.65 | 363.01 | -193.11 | -493.66 |
Free Cash Flow Per Share | 1.71 | 3.37 | 2.61 | -1.39 | -3.55 |
Dividend Per Share | - | 0.450 | 0.450 | 0.450 | - |
Gross Margin | 26.41% | 21.10% | 20.21% | 18.73% | 16.56% |
Operating Margin | 15.29% | 11.54% | 10.64% | 8.67% | 8.38% |
Profit Margin | 9.33% | 8.82% | 5.59% | 5.23% | 5.73% |
Free Cash Flow Margin | 2.43% | 5.60% | 4.13% | -2.62% | -8.90% |
EBITDA | 2,180 | 1,438 | 1,246 | 889.56 | 654.52 |
EBITDA Margin | 19.62% | 15.35% | 14.18% | 12.06% | 11.80% |
D&A For EBITDA | 480.66 | 357.39 | 311.39 | 250.48 | 189.44 |
EBIT | 1,699 | 1,081 | 934.57 | 639.07 | 465.09 |
EBIT Margin | 15.29% | 11.54% | 10.64% | 8.67% | 8.38% |
Effective Tax Rate | 25.48% | 23.67% | 28.21% | 24.89% | 15.55% |
Revenue as Reported | 11,111 | 9,699 | 8,859 | 7,448 | 5,587 |
Advertising Expenses | - | 65.2 | 43.1 | 69.48 | 23.68 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.